CBD modulating effect of expectancies in treatment of stress and psychological distress

CBD modulating effect of expectancies in treatment of stress and psychological distress - TERPENE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033147

Enrollment

120

Registered

2023-11-28

Start date

2023-11-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perceived stress

Interventions

Group 1: 10% full spectrum CBD-oil & booster-placebo Group 2: 10% full spectrum CBD-oil & blocker-placebo Group 3: 10% full spectrum CBD-oil & placebo

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: students German speaking stress level (PSS-10 >= 23)

Exclusion criteria

Exclusion criteria: allergies against ingredients of CBD and Placebo known chronic or acute disease or psychatric disorder regular intake of medication regular intake of CBD product within the last 4 weeks body weight >85kg

Design outcomes

Primary

Measure	Time frame
change in stress (PSS-10) from day 14 to day 21 of participation	—

Secondary

Measure	Time frame
change in psychological distress (DASS-21) from day 14 to day 21 of participation	—

Countries

Germany

Contacts

Public ContactAlexander Winkler

Justus-Liebig-Universität Gießen

Alexander.Winkler@psychol.uni-giessen.de+49 641 99-26084

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026